Indo Global Exchange
Indo Global Exchange(s) PTE, Ltd., a development stage company, focuses on providing financial market access to customers worldwide. Its platform provides financial market access to approximately 30 equity exchanges for trading in securities and contract for differences. The company is based in Jakarta, Indonesia.
Indo Global Exchange (IGEX) - Net Assets
Latest net assets as of April 2025: $5.00 Million USD
Based on the latest financial reports, Indo Global Exchange (IGEX) has net assets worth $5.00 Million USD as of April 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.51 Million) and total liabilities ($1.51 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.00 Million |
| % of Total Assets | 76.82% |
| Annual Growth Rate | 11.13% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 55.23 |
Indo Global Exchange - Net Assets Trend (2008–2024)
This chart illustrates how Indo Global Exchange's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Indo Global Exchange (2008–2024)
The table below shows the annual net assets of Indo Global Exchange from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-07-31 | $150.89K | -72.40% |
| 2023-07-31 | $546.63K | -9.67% |
| 2022-07-31 | $605.13K | +267.82% |
| 2015-07-31 | $-360.57K | 0.00% |
| 2014-07-31 | $-360.57K | -686.95% |
| 2013-07-31 | $-45.82K | -266.64% |
| 2009-07-31 | $-12.50K | -144.85% |
| 2008-07-31 | $27.87K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Indo Global Exchange's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1166373600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $6.11 Million | 4052.27% |
| Other Comprehensive Income | $-6.11 Million | -4052.27% |
| Other Components | $11.86 Million | 7858.50% |
| Total Equity | $150.89K | 100.00% |
Indo Global Exchange Competitors by Market Cap
The table below lists competitors of Indo Global Exchange ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Medicale Corp
PINK:MCLE
|
$619.89K |
|
Chakana Copper Corp
OTCQB:CHKKF
|
$619.97K |
|
Macquarie Bank Limited
AU:MBLPD
|
$620.09K |
|
GRIFFON
BE:GFF
|
$620.65K |
|
Leafly Holdings Inc
NASDAQ:LFLY
|
$619.39K |
|
EGR EXPL LTD
F:Z0R
|
$619.17K |
|
Crown Point Energy Inc
PINK:CWVLF
|
$619.09K |
|
Aesthetic Medical International Holdings Group Limited
NASDAQ:PAIYY
|
$618.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Indo Global Exchange's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 546,634 to 150,887, a change of -395,747 (-72.4%).
- Net loss of 751,000 reduced equity.
- Other comprehensive income decreased equity by 6,872,152.
- Other factors increased equity by 7,227,405.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-751.00K | -497.72% |
| Other Comprehensive Income | $-6.87 Million | -4554.5% |
| Other Changes | $7.23 Million | +4789.95% |
| Total Change | $- | -72.40% |
Book Value vs Market Value Analysis
This analysis compares Indo Global Exchange's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 24.31x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.56x to 24.31x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-07-31 | $0.00 | $0.00 | x |
| 2009-07-31 | $0.00 | $0.00 | x |
| 2012-07-31 | $0.00 | $0.00 | x |
| 2013-07-31 | $0.00 | $0.00 | x |
| 2014-07-31 | $0.00 | $0.00 | x |
| 2015-07-31 | $0.00 | $0.00 | x |
| 2016-07-31 | $0.00 | $0.00 | x |
| 2019-07-31 | $0.00 | $0.00 | x |
| 2020-07-31 | $0.00 | $0.00 | x |
| 2021-07-31 | $0.00 | $0.00 | x |
| 2022-07-31 | $0.00 | $0.00 | x |
| 2023-07-31 | $0.00 | $0.00 | x |
| 2024-07-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Indo Global Exchange utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -497.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 44.49x
- Recent ROE (-497.72%) is below the historical average (-84.73%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -153.71% | 0.00% | 0.00x | 1.27x | $-45.62K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-39.11K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $273.20 |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $273.20 |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $273.20 |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-33.62K |
| 2014 | 0.00% | -4021.47% | 0.73x | 0.00x | $-392.47K |
| 2015 | 0.00% | -4025.90% | 0.73x | 0.00x | $-392.94K |
| 2016 | 0.00% | -23624.92% | 0.00x | 0.00x | $-4.55 Million |
| 2019 | 0.00% | -238.54% | 0.00x | 0.00x | $6.56K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $42.50K |
| 2022 | -405.21% | -70359.28% | 0.00x | 1.80x | $-2.51 Million |
| 2023 | -129.52% | 0.00% | 0.00x | 1.99x | $-762.66K |
| 2024 | -497.72% | 0.00% | 0.00x | 44.49x | $-766.09K |
Industry Comparison
This section compares Indo Global Exchange's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Indo Global Exchange (IGEX) | $5.00 Million | -153.71% | 0.30x | $619.54K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |